Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD.

Chattopadhyay A, Navab M, Hough G, Grijalva V, Mukherjee P, Fogelman HR, Hwang LH, Faull KF, Lusis AJ, Reddy ST, Fogelman AM.

J Lipid Res. 2016 May;57(5):832-47. doi: 10.1194/jlr.M064352. Epub 2016 Mar 9.

PMID:
26965826
2.

Serum Autotaxin/ENPP2 correlates with insulin resistance in older humans with obesity.

Reeves VL, Trybula JS, Wills RC, Goodpaster BH, Dubé JJ, Kienesberger PC, Kershaw EE.

Obesity (Silver Spring). 2015 Dec;23(12):2371-6. doi: 10.1002/oby.21232. Epub 2015 Nov 2.

3.

Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration.

Nan L, Wei J, Jacko AM, Culley MK, Zhao J, Natarajan V, Ma H, Zhao Y.

Biochim Biophys Acta. 2016 Feb;1863(2):229-35. doi: 10.1016/j.bbamcr.2015.11.012. Epub 2015 Nov 17.

PMID:
26597701
4.

Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA1, LPA2, and LPA3.

Alcántara-Hernández R, Hernández-Méndez A, Campos-Martínez GA, Meizoso-Huesca A, García-Sáinz JA.

PLoS One. 2015 Oct 16;10(10):e0140583. doi: 10.1371/journal.pone.0140583. eCollection 2015.

5.

LPA Promotes T Cell Recruitment through Synthesis of CXCL13.

Hui W, Zhao C, Bourgoin SG.

Mediators Inflamm. 2015;2015:248492. doi: 10.1155/2015/248492. Epub 2015 Aug 3.

6.

Lysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering.

Binder BY, Williams PA, Silva EA, Leach JK.

Tissue Eng Part B Rev. 2015 Dec;21(6):531-42. doi: 10.1089/ten.TEB.2015.0107. Epub 2015 Jul 14.

PMID:
26035484
7.

Uncovering unique roles of LPA receptors in the tumor microenvironment.

Lee SC, Fujiwara Y, Tigyi GJ.

Receptors Clin Investig. 2015;2(1). pii: e440.

8.

Membrane-derived phospholipids control synaptic neurotransmission and plasticity.

García-Morales V, Montero F, González-Forero D, Rodríguez-Bey G, Gómez-Pérez L, Medialdea-Wandossell MJ, Domínguez-Vías G, García-Verdugo JM, Moreno-López B.

PLoS Biol. 2015 May 21;13(5):e1002153. doi: 10.1371/journal.pbio.1002153. eCollection 2015 May.

9.

Krüppel-like factor 5 incorporates into the β-catenin/TCF complex in response to LPA in colon cancer cells.

Guo L, He P, No YR, Yun CC.

Cell Signal. 2015 May;27(5):961-8. doi: 10.1016/j.cellsig.2015.02.005. Epub 2015 Feb 12.

10.

Melanoma cells break down LPA to establish local gradients that drive chemotactic dispersal.

Muinonen-Martin AJ, Susanto O, Zhang Q, Smethurst E, Faller WJ, Veltman DM, Kalna G, Lindsay C, Bennett DC, Sansom OJ, Herd R, Jones R, Machesky LM, Wakelam MJ, Knecht DA, Insall RH.

PLoS Biol. 2014 Oct 14;12(10):e1001966. doi: 10.1371/journal.pbio.1001966. eCollection 2014 Oct.

11.

Design and synthesis of sulfamoyl benzoic acid analogues with subnanomolar agonist activity specific to the LPA2 receptor.

Patil R, Fells JI, Szabó E, Lim KG, Norman DD, Balogh A, Patil S, Strobos J, Miller DD, Tigyi GJ.

J Med Chem. 2014 Aug 28;57(16):7136-40. doi: 10.1021/jm5007116. Epub 2014 Aug 12.

12.

Convergence of vitamin D and lysophosphatidic acid signaling in stimulating human osteoblast maturation.

Mansell JP.

Front Physiol. 2014 Jul 11;5:263. doi: 10.3389/fphys.2014.00263. eCollection 2014. No abstract available.

13.

The roles of sphingosine kinase 1 and 2 in regulating the metabolome and survival of prostate cancer cells.

Tonelli F, Alossaimi M, Natarajan V, Gorshkova I, Berdyshev E, Bittman R, Watson DG, Pyne S, Pyne NJ.

Biomolecules. 2013 Jun 10;3(2):316-33. doi: 10.3390/biom3020316.

14.

Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response.

Hu J, Oda SK, Shotts K, Donovan EE, Strauch P, Pujanauski LM, Victorino F, Al-Shami A, Fujiwara Y, Tigyi G, Oravecz T, Pelanda R, Torres RM.

J Immunol. 2014 Jul 1;193(1):85-95. doi: 10.4049/jimmunol.1300429. Epub 2014 Jun 2.

15.

Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.

Chuang YW, Chang WM, Chen KH, Hong CZ, Chang PJ, Hsu HC.

PLoS One. 2014 May 30;9(5):e95180. doi: 10.1371/journal.pone.0095180. eCollection 2014.

16.

Challenges in accurate quantitation of lysophosphatidic acids in human biofluids.

Onorato JM, Shipkova P, Minnich A, Aubry AF, Easter J, Tymiak A.

J Lipid Res. 2014 Aug;55(8):1784-96. doi: 10.1194/jlr.D050070. Epub 2014 May 28.

17.

Lysophosphatidic acid signaling in late cleavage and blastocyst stage bovine embryos.

Torres AC, Boruszewska D, Batista M, Kowalczyk-Zieba I, Diniz P, Sinderewicz E, Saulnier-Blache JS, Woclawek-Potocka I, Lopes-da-Costa L.

Mediators Inflamm. 2014;2014:678968. doi: 10.1155/2014/678968. Epub 2014 Apr 15.

18.

LPA receptor signaling: pharmacology, physiology, and pathophysiology.

Yung YC, Stoddard NC, Chun J.

J Lipid Res. 2014 Jul;55(7):1192-214. doi: 10.1194/jlr.R046458. Epub 2014 Mar 18.

19.

Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis.

Montesi SB, Mathai SK, Brenner LN, Gorshkova IA, Berdyshev EV, Tager AM, Shea BS.

BMC Pulm Med. 2014 Jan 27;14:5. doi: 10.1186/1471-2466-14-5.

20.

Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.

Oda SK, Strauch P, Fujiwara Y, Al-Shami A, Oravecz T, Tigyi G, Pelanda R, Torres RM.

Cancer Immunol Res. 2013 Oct;1(4):245-55. doi: 10.1158/2326-6066.CIR-13-0043-T.

Items per page

Supplemental Content

Write to the Help Desk